Prolonged extracorporeal membrane oxygenation therapy for severe acute respiratory distress syndrome in a child affected by rituximab-resistant autoimmune hemolytic anemia: a case report
<p>Abstract</p> <p>Introduction</p> <p>Autoimmune hemolytic anemia in children younger than 2 years of age is usually characterized by a severe course, with a mortality rate of approximately 10%. The prolonged immunosuppression following specific treatment may be associ...
Main Authors: | Beretta Chiara, Leoni Veronica, Rossi Mario Renato, Jankovic Momcilo, Patroniti Nicolo, Foti Giuseppe, Biagi Ettore |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-04-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/3/1/6443 |
Similar Items
-
Cold autoimmune hemolytic anemia resolved by rituximab
by: Palombi Massimiliano, et al.
Published: (2010-01-01) -
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
by: Irina Murakhovskaya
Published: (2020-12-01) -
Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
by: Claudio Fozza, et al.
Published: (2011-01-01) -
Erythrodermic psoriasis after rituximab treatment in a patient with autoimmune hemolytic anemia
by: Dimitra Koumaki, et al.
Published: (2021-01-01) -
TREATMENT OF AUTOIMMUNE HEMOLYTIC ANAEMIA WITH RITUXIMAB
by: Uroš Mlakar
Published: (2004-12-01)